Personal tools

MCL coexpression mm9:292: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 3: Line 3:
|coexpression_dpi_cluster_scores_median=0,0,0,0.0573828993656285,0.062908599447199,0,0.0911788108631387,0.864861282589211,0.380892504618774,0.357877580566854,0.136894152503244,0.0787347879396902,0.729564525854225,0.676862313506086,0,0,0,0.190346765729239,0.149632666139897,0.153628809860867,0,0.0411126530948397,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0415192773019274,0.157045365050363,0,0,0,0.200913802025349,0,0,0.0514985917256918,0.0419359757688424,0.0113260474263052,0,0,0,0,0,0,0.22301034595168,0.501892311714437,0.479512370320439,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.91796371343602,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.100004302423367,0,0,0,0,0,0,0,0,0.00183184857363957,0,0,0,0,0,0,0,0,0.120046814898098,0.190778633576452,0.140259928189304,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.180325425270187,0.108620321524749,0,0,0,0,0,0,0,0,0,0,0,0.0075698410043086,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0156529493032097,0,0,0,0,0,0,0,0,0,0,0.0442950572662417,0,0.033405693853525,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0383569641205167,0,0,0,0,0,0,0,0,0,0,0.0138800150590559,0,0,0,0,0,0,0,0,0,0,0,0,0.201993230613794,0.230386905221361,0.15063362961962,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0463148334396615,0,0,0,0.0715236385554987,0.0787037500278776,0.0215126239715145,0.0598244186619439,0.0798802230592418,0.0467520571956962,0.0797788474440915,0.0642863497013468,0.108916251331407,0.117221673010779,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|coexpression_dpi_cluster_scores_median=0,0,0,0.0573828993656285,0.062908599447199,0,0.0911788108631387,0.864861282589211,0.380892504618774,0.357877580566854,0.136894152503244,0.0787347879396902,0.729564525854225,0.676862313506086,0,0,0,0.190346765729239,0.149632666139897,0.153628809860867,0,0.0411126530948397,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0415192773019274,0.157045365050363,0,0,0,0.200913802025349,0,0,0.0514985917256918,0.0419359757688424,0.0113260474263052,0,0,0,0,0,0,0.22301034595168,0.501892311714437,0.479512370320439,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.91796371343602,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.100004302423367,0,0,0,0,0,0,0,0,0.00183184857363957,0,0,0,0,0,0,0,0,0.120046814898098,0.190778633576452,0.140259928189304,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.180325425270187,0.108620321524749,0,0,0,0,0,0,0,0,0,0,0,0.0075698410043086,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0156529493032097,0,0,0,0,0,0,0,0,0,0,0.0442950572662417,0,0.033405693853525,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0383569641205167,0,0,0,0,0,0,0,0,0,0,0.0138800150590559,0,0,0,0,0,0,0,0,0,0,0,0,0.201993230613794,0.230386905221361,0.15063362961962,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0463148334396615,0,0,0,0.0715236385554987,0.0787037500278776,0.0215126239715145,0.0598244186619439,0.0798802230592418,0.0467520571956962,0.0797788474440915,0.0642863497013468,0.108916251331407,0.117221673010779,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|gostat_on_MCL_coexpression=GO:0033549;MAP kinase phosphatase activity;0.039921137030804;19252!GO:0017017;MAP kinase tyrosine/serine/threonine phosphatase activity;0.039921137030804;19252!
|gostat_on_MCL_coexpression=GO:0033549;MAP kinase phosphatase activity;0.039921137030804;19252!GO:0017017;MAP kinase tyrosine/serine/threonine phosphatase activity;0.039921137030804;19252!
|ontology_enrichment_celltype=CL:0000838!6.60e-19!12;CL:0000988!2.73e-18!32;CL:0002032!2.73e-18!32;CL:0000037!2.73e-18!32;CL:0000566!2.73e-18!32;CL:0000837!2.73e-18!32;CL:0000791!7.15e-18!9;CL:0000789!7.15e-18!9;CL:0002420!7.15e-18!9;CL:0002419!7.15e-18!9;CL:0000790!7.15e-18!9;CL:0000542!3.12e-17!13;CL:0000051!3.12e-17!13;CL:0000084!4.21e-17!11;CL:0000827!4.21e-17!11;CL:0000624!5.52e-16!8;CL:0002242!1.79e-13!16;CL:0002031!6.93e-13!25;CL:0002320!1.05e-12!46;CL:0000134!1.05e-12!46;CL:0000738!1.62e-12!17;CL:0002087!1.62e-12!17;CL:0000893!3.94e-12!6;CL:0002489!3.94e-12!6;CL:0000898!3.94e-12!6;CL:0000809!3.94e-12!6;CL:0000810!3.94e-12!6;CL:0000895!3.94e-12!6;CL:0000808!3.94e-12!6;CL:0000894!3.94e-12!6;CL:0000806!3.94e-12!6;CL:0000807!3.94e-12!6;CL:0000805!3.94e-12!6;CL:0002425!3.94e-12!6;CL:0002436!3.94e-12!6;CL:0002427!3.94e-12!6;CL:0002428!3.94e-12!6;CL:0002429!3.94e-12!6;CL:0002433!3.94e-12!6;CL:0002431!3.94e-12!6;CL:0002432!3.94e-12!6;CL:0000219!5.00e-10!54;CL:0000034!7.04e-09!97;CL:0000723!3.85e-07!91;CL:0000048!3.85e-07!91
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0002370!2.78e-19!23;UBERON:0000974!2.78e-19!23;UBERON:0004807!2.78e-19!23;UBERON:0005058!2.78e-19!23;UBERON:0003351!2.78e-19!23;UBERON:0009113!2.78e-19!23;UBERON:0003295!2.78e-19!23;UBERON:0009722!2.78e-19!23;UBERON:0005562!2.78e-19!23;UBERON:0007690!2.78e-19!23;UBERON:0006562!2.73e-18!24;UBERON:0003408!2.73e-18!24;UBERON:0001557!2.73e-18!24;UBERON:0001042!2.73e-18!24;UBERON:0008814!2.73e-18!24;UBERON:0009145!2.73e-18!24;UBERON:0000072!9.22e-16!27;UBERON:0002193!6.09e-15!48;UBERON:0002405!6.09e-15!48;UBERON:0002390!1.01e-14!45;UBERON:0003061!1.01e-14!45;UBERON:0004177!2.27e-14!29;UBERON:0005057!2.27e-14!29;UBERON:0000077!6.06e-13!35;UBERON:0002384!1.05e-12!46;UBERON:0000065!1.17e-12!41;UBERON:0001004!3.08e-12!42;UBERON:0000490!4.18e-12!66;UBERON:0003929!5.25e-12!55;UBERON:0005911!2.89e-11!69;UBERON:0000063!3.65e-11!35;UBERON:0007811!9.79e-11!36;UBERON:0003081!1.68e-09!87;UBERON:0000153!2.60e-08!43;UBERON:0000055!2.82e-08!5;UBERON:0007500!2.82e-08!5;UBERON:0001981!2.82e-08!5;UBERON:0002049!2.82e-08!5;UBERON:0007798!2.82e-08!5;UBERON:0004537!2.82e-08!5;UBERON:0006965!2.82e-08!5
}}
}}

Revision as of 19:14, 11 October 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr10:18735503..18735513,+p@chr10:18735503..18735513
+
Mm9::chr11:106077832..106077846,+p7@Ddx42
Mm9::chr11:106640128..106640133,-p@chr11:106640128..106640133
-
Mm9::chr11:48741726..48741731,-p@chr11:48741726..48741731
-
Mm9::chr11:48807684..48807688,-p1@Tgtp1
p1@Tgtp2
Mm9::chr11:48877704..48877708,-p2@Tgtp1
p2@Tgtp2
Mm9::chr11:48900808..48900825,-p@chr11:48900808..48900825
-
Mm9::chr11:53577462..53577476,-p@chr11:53577462..53577476
-
Mm9::chr11:54769726..54769742,+p@chr11:54769726..54769742
+
Mm9::chr11:86297814..86297852,-p@chr11:86297814..86297852
-
Mm9::chr13:113230195..113230209,-p@chr13:113230195..113230209
-
Mm9::chr13:42148379..42148391,+p@chr13:42148379..42148391
+
Mm9::chr15:27715131..27715143,-p@chr15:27715131..27715143
-
Mm9::chr17:26645134..26645152,-p5@Dusp1
Mm9::chr17:26645159..26645192,-p3@Dusp1
Mm9::chr17:64681746..64681757,+p@chr17:64681746..64681757
+
Mm9::chr18:35900045..35900092,-p3@Tmem173
Mm9::chr3:148989729..148989732,-p@chr3:148989729..148989732
-
Mm9::chr4:132071343..132071349,-p@chr4:132071343..132071349
-
Mm9::chr5:114442415..114442421,-p@chr5:114442415..114442421
-
Mm9::chr5:135484708..135484730,-p@chr5:135484708..135484730
-
Mm9::chr5:139858874..139858903,-p@chr5:139858874..139858903
-
Mm9::chr6:128374733..128374747,+p@chr6:128374733..128374747
+
Mm9::chr6:48658357..48658367,+p@chr6:48658357..48658367
+
Mm9::chr7:132634885..132634897,-p@chr7:132634885..132634897
-
Mm9::chr7:135111618..135111623,+p@chr7:135111618..135111623
+
Mm9::chr9:119891850..119891862,+p@chr9:119891850..119891862
+
Mm9::chr9:7873196..7873213,+p@chr9:7873196..7873213
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

GO IDGO nameFDR corrected p-value
GO:0033549MAP kinase phosphatase activity0.039921137030804
GO:0017017MAP kinase tyrosine/serine/threonine phosphatase activity0.039921137030804



Relative expression of the co-expression cluster over median <br>Analyst:




Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>

Cell Type
Ontology termp-valuen
lymphoid lineage restricted progenitor cell6.60e-1912
hematopoietic cell2.73e-1832
hematopoietic oligopotent progenitor cell2.73e-1832
hematopoietic stem cell2.73e-1832
angioblastic mesenchymal cell2.73e-1832
hematopoietic multipotent progenitor cell2.73e-1832
mature alpha-beta T cell7.15e-189
alpha-beta T cell7.15e-189
immature T cell7.15e-189
mature T cell7.15e-189
immature alpha-beta T cell7.15e-189
lymphocyte3.12e-1713
common lymphoid progenitor3.12e-1713
T cell4.21e-1711
pro-T cell4.21e-1711
CD4-positive, alpha-beta T cell5.52e-168
nucleate cell1.79e-1316
hematopoietic lineage restricted progenitor cell6.93e-1325
connective tissue cell1.05e-1246
mesenchymal cell1.05e-1246
leukocyte1.62e-1217
nongranular leukocyte1.62e-1217
thymocyte3.94e-126
double negative thymocyte3.94e-126
naive T cell3.94e-126
double-positive, alpha-beta thymocyte3.94e-126
CD4-positive, alpha-beta thymocyte3.94e-126
naive thymus-derived CD4-positive, alpha-beta T cell3.94e-126
DN4 thymocyte3.94e-126
DN1 thymic pro-T cell3.94e-126
DN2 thymocyte3.94e-126
DN3 thymocyte3.94e-126
immature single positive thymocyte3.94e-126
early T lineage precursor3.94e-126
mature CD4 single-positive thymocyte3.94e-126
resting double-positive thymocyte3.94e-126
double-positive blast3.94e-126
CD69-positive double-positive thymocyte3.94e-126
CD69-positive, CD4-positive single-positive thymocyte3.94e-126
CD4-positive, CD8-intermediate double-positive thymocyte3.94e-126
CD24-positive, CD4 single-positive thymocyte3.94e-126
motile cell5.00e-1054
stem cell7.04e-0997
somatic stem cell3.85e-0791
multi fate stem cell3.85e-0791

Uber Anatomy
Ontology termp-valuen
thymus2.78e-1923
neck2.78e-1923
respiratory system epithelium2.78e-1923
hemolymphoid system gland2.78e-1923
pharyngeal epithelium2.78e-1923
thymic region2.78e-1923
pharyngeal gland2.78e-1923
entire pharyngeal arch endoderm2.78e-1923
thymus primordium2.78e-1923
early pharyngeal endoderm2.78e-1923
pharynx2.73e-1824
gland of gut2.73e-1824
upper respiratory tract2.73e-1824
chordate pharynx2.73e-1824
pharyngeal arch system2.73e-1824
pharyngeal region of foregut2.73e-1824
segment of respiratory tract9.22e-1627
hemolymphoid system6.09e-1548
immune system6.09e-1548
hematopoietic system1.01e-1445
blood island1.01e-1445
hemopoietic organ2.27e-1429
immune organ2.27e-1429
mixed endoderm/mesoderm-derived structure6.06e-1335
connective tissue1.05e-1246
respiratory tract1.17e-1241
respiratory system3.08e-1242
unilaminar epithelium4.18e-1266
gut epithelium5.25e-1255
endo-epithelium2.89e-1169
organ segment3.65e-1135
craniocervical region9.79e-1136
lateral plate mesoderm1.68e-0987
anterior region of body2.60e-0843
vessel2.82e-085
epithelial tube open at both ends2.82e-085
blood vessel2.82e-085
vasculature2.82e-085
vascular system2.82e-085
blood vasculature2.82e-085
vascular cord2.82e-085


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=MCL_coexpression_mm9:292&oldid=2155199"